Pfizer-Biotech\u2019s (NYSE: PFE) Covid-19 vaccine received full approval from the U.S. Food and Drug Administration on Monday. An action that is expected to increase confidence in the shot as pandemic numbers continue to surge.<\/p>\n\n\n\n
The new label is the strongest endorsement from the FDA and the shot is considered to have extensive evidence of it\u2019s safety following month\u2019s of operating under an emergency use authorization.<\/p>\n\n\n\n
\u201cThe FDA\u2019s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA\u2019s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,\u201d said Acting FDA Commissioner Janet Woodcock, M.D. \u201cWhile millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today\u2019s milestone puts us one step closer to altering the course of this pandemic in the U.S.\u201d<\/p>\n\n\n\n
According to Pfizer, the U.S. is now the first country to completely approve the vaccine. The pharmaceutical\u2019s CEO Albert Bourla stated that he hoped the determination “will help increase confidence in our vaccine, as vaccination remains the best tool we have to help protect lives.”<\/p>\n\n\n\n
“While all three COVID vaccines have met FDA’s strict standards for emergency use, this FDA approval should give added confidence that this vaccine is safe and effective. If you’re not vaccinated yet, now is the time.”<\/p>